BM8-T202 – ‘Stomach friendly’ Anti-inflammatory drug candidate
The Anti-inflammatory pipeline is focused on exploiting the first-in-class discovery of a ‘stomach friendly’ anti-inflammatory.
The potency of this new anti-inflammatory treatment, during animal studies, was found to have comparable strength to current anti-inflammatory drugs without the GI side effects.
Scientific studies: To see an overview of the R&D program and scientific studies comparing Bioactive extracts to other pharmaceutical substances click on Bioactive Research
Drug development collaborations are currently being formed – this web page will be under development over the next few months whilst contractual arrangements & patents are finalised, please stay tuned…